Rajasthan's Commissionerate of Food Safety and Drugs Control has ordered the immediate withdrawal of seven substandard medicines — including antibiotics (Cefixime, Cefuroxime Axetil, Ciprofloxacin), anti-helminthic Albendazole, cough medicines, and corticosteroid Methylprednisolone — after laboratory testing flagged quality failures; manufacturers are spread across Rajasthan, Himachal Pradesh, Delhi, and Uttarakhand, with the antibiotics being particularly concerning due to antimicrobial-resistance risk.

The Rajasthan health department has ordered the immediate withdrawal of seven medicines after laboratory testing found them to be substandard. The action was taken by the Commissionerate of Food Safety and Drugs Control to protect public health and prevent use of poor-quality medicines that could lead to treatment failure and serious health risks. The recalled medicines include (1) Cefixime Oral Suspension IP — sold as 'Loraxim' dry syrup; commonly used for bacterial infections (throat, ear, bronchitis, urinary tract); (2) Albendazole tablets — anti-helminthic for worm infestations and parasitic diseases; (3) Istocuf-LS drops containing Ambroxol Hydrochloride + Levosalbutamol + Guaifenesin for cough treatment; (4) Methylprednisolone tablets sold as 'Methyloactive-4' for inflammation control; (5) Okuff-DX syrup for cough relief; (6) Cefuroxime Axetil tablets for bacterial infections; and (7) Ciprofloxacin tablets — broad-spectrum antibiotic. State Drug Controller Ajay Phatak said all Drugs Control Officers across Rajasthan have been instructed to stop sale, distribution, and use of these medicines immediately, with stock removal from pharmacies, hospitals, and supply chains. Manufacturers of these medicines are located in Rajasthan, Himachal Pradesh, Delhi, and Uttarakhand — indicating the issue involves multiple production centres across India. Substandard antibiotics are particularly concerning because poor-quality drugs can accelerate antimicrobial resistance (AMR) — a global public-health crisis recognised by the World Health Organization.

Action

Immediate withdrawal of seven substandard medicines ordered

Ordering authority

Commissionerate of Food Safety and Drugs Control, Rajasthan

State Drug Controller

Ajay Phatak

Basis of recall

Laboratory testing found medicines to be substandard

Drug 1 — Cefixime Oral Suspension IP

Sold as 'Loraxim' dry syrup; used for bacterial infections (throat, ear, bronchitis, urinary tract)

Drug 2 — Albendazole tablets

Anti-helminthic drug for worm infestations and parasitic diseases

Drug 3 — Istocuf-LS drops

Contains Ambroxol Hydrochloride + Levosalbutamol + Guaifenesin; cough treatment

Drug 4 — Methylprednisolone tablets

Sold as 'Methyloactive-4'; corticosteroid for inflammation control

Drug 5 — Okuff-DX syrup

Cough-relief formulation

Drug 6 — Cefuroxime Axetil tablets

Antibiotic for bacterial infections

Drug 7 — Ciprofloxacin tablets

Broad-spectrum antibiotic

Manufacturer locations

Rajasthan + Himachal Pradesh + Delhi + Uttarakhand — multi-state supply-chain involvement

Key risk flagged

Substandard antibiotics accelerate antimicrobial resistance (AMR) — WHO-recognised global health crisis

Enforcement directive

All Drugs Control Officers instructed to stop sale, distribution, and use; remove stock from pharmacies, hospitals, supply chains

• •CDSCO: Central Drugs Standard Control Organisation — national regulatory authority for drugs and cosmetics under the Directorate General of Health Services, Ministry of Health and Family Welfare; licenses clinical trials, new drug approvals, imports
• •Drugs Controller General of India (DCGI): Head of CDSCO; approves new drugs, clinical trials, and manufacturing licenses under the Drugs and Cosmetics Act, 1940
• •Drugs and Cosmetics Act, 1940: Primary Indian legislation regulating import, manufacture, distribution, and sale of drugs and cosmetics; complemented by Drugs and Cosmetics Rules, 1945
• •Substandard and falsified medicines (WHO definitions): SUBSTANDARD = authorised medicines failing to meet quality standards or specifications. FALSIFIED = deliberately/fraudulently misrepresent identity, composition, or source
• •Antimicrobial Resistance (AMR): Phenomenon where microorganisms (bacteria, viruses, fungi, parasites) evolve resistance to antimicrobial drugs; WHO identifies as top 10 global health threats; drives 'silent pandemic'
• •National Action Plan on AMR (India): Launched 2017 by Government of India; aligned with WHO's Global Action Plan on AMR (2015); focuses on awareness, surveillance, infection prevention, rational use, R&D
• •Cefixime: Third-generation cephalosporin oral antibiotic; used for respiratory, urinary, and gastrointestinal bacterial infections
• •Cefuroxime Axetil: Second-generation cephalosporin oral antibiotic; used for respiratory and skin infections
• •Ciprofloxacin: Fluoroquinolone broad-spectrum antibiotic; used for diverse bacterial infections including urinary, gastrointestinal, and respiratory
• •Albendazole: Broad-spectrum anti-helminthic (de-worming) drug; effective against roundworms, tapeworms, flukes; part of National Deworming Day programme in India
• •Methylprednisolone: Corticosteroid used to reduce inflammation and suppress immune responses; treats autoimmune conditions, allergic reactions, and severe inflammatory conditions
• •National Deworming Day (India): Biannual mass-administration of Albendazole to children and adolescents; led by Ministry of Health; first observed 10 February 2015

• Trap · Substandard vs falsified medicines (WHO framework)

  Correct: SUBSTANDARD = authorised medicines that FAIL TO MEET QUALITY standards or specifications (e.g., wrong dosage strength, degraded active ingredient). FALSIFIED = DELIBERATELY/FRAUDULENTLY MISREPRESENT identity, composition, or source (counterfeits). The Rajasthan recall involves SUBSTANDARD medicines specifically — authorised products failing quality tests, not deliberate counterfeits.

• Trap · State vs Central regulatory roles

  Correct: STATE = manufacturing licensing, sales/distribution enforcement, recalls (e.g., Rajasthan's Commissionerate of Food Safety and Drugs Control). CENTRAL = CDSCO under DCGI — new drug approvals, clinical trials, imports, banned drugs, national standards. BOTH operate under the Drugs and Cosmetics Act, 1940. This is concurrent federalism — don't assign only state or only central roles.

• Trap · Drugs and Cosmetics Act year

  Correct: 1940 — NOT 1948 (that's Pharmacy Act) or 1954 (that's Drugs and Magic Remedies Objectionable Advertisements Act). Drugs and Cosmetics Rules = 1945 (five years after the Act).

• Trap · Brand name vs generic name

  Correct: CEFIXIME = generic active ingredient. LORAXIM = brand name of the recalled Cefixime Oral Suspension IP. METHYLPREDNISOLONE = generic. METHYLOACTIVE-4 = brand name. Brand/generic distinction often tested — know both for the recalled drugs.

• Trap · Antibiotic classes in the recall

  Correct: Cefixime = 3rd-generation CEPHALOSPORIN. Cefuroxime Axetil = 2nd-generation CEPHALOSPORIN (same class, different generation). Ciprofloxacin = FLUOROQUINOLONE (completely different class). Three antibiotics, two classes — not one single class.

• Trap · Ajay Phatak's role

  Correct: State Drug Controller — NOT State Health Minister, NOT Chief Medical Officer. Specifically the bureaucratic head of drug-control enforcement in Rajasthan.

• Trap · Albendazole mechanism

  Correct: ANTI-HELMINTHIC (for WORM infestations) — NOT antibiotic, NOT antifungal, NOT antiviral. It's part of India's National Deworming Day programme for children.